Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by enriquesuaveon Mar 08, 2022 1:04pm
302 Views
Post# 34496040

RE:RE:RE:Reading the tea leaves...

RE:RE:RE:Reading the tea leaves...

I perfectly agree there, as they are maybe waiting for more data 3, 6, 9 and 12 months assessments.  I guess it could sometimes take a bit more time,  My feeling is possibly this week still or if not then next week. However we are all guessing, but we at least know it's "soon".


Eoganacht wrote: If they follow the same pattern as the last 7 newsletters it will be a Monday or a Tuesday. But there's no guarantee they will follow the same pattern, and there's not even any guarantee it will be released by next week! As this is a very important news release they're probably giving the timing a lot of thought and want to take full advantage of the impact it could have.

Maybe they want to include a couple extra 90 day patients from early December. That's just a stab in the dark.
 

99942Apophis wrote: One time when I had a conversation with Kristina she brought up the subject of news releases and stated she didn't want their news release timings to become predictable. You saw my possible time frame from Feb. 22 to March 11 so we are still within that zone I take it your suggestion would take aim at this coming Monday! If so that would be highly probable according to your observation. 
Sure do wonder if this later release has to do with anything monumental or just staff shortage, your guess if any?




<< Previous
Bullboard Posts
Next >>